GlassScriptPhysician profile
Christopher J Gonzales
NPI 1790198802
$13,383.22
in general payments reported to CMS, 2019-2025
9 companies · $1,678 in 2025
The $1,678 reported for 2025 was more than what 75% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $35.88 · 2022: $171 · 2023: $57.08 · 2024: $11K · 2025: $1,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Travel and Lodging: $2,333 · Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,165.78 |
| Travel and Lodging | $2,333.06 |
| Food and Beverage | $677.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,064.26 | 2024-2025 | |
| Medtronic, INC. | $130.70 | 2022 | |
| Teleflex LLC | $40.20 | 2022 | |
| Kerecis Limited | $38.48 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Acumed LLC | $38.02 | 2023 | Acumed |
| Kls-Martin L.P. | $23.15 | 2020 | |
| Avanos Medical | $19.06 | 2023 | Closed Suction |
| Smith+Nephew, INC. | $16.62 | 2024 | Pico |
| Davol INC. | $12.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Gonzales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.